GIP: The Forgotten Incretin

GIP (glucose-dependent insulinotropic polypeptide) is the other major incretin hormone, secreted by duodenal K-cells. Like GLP-1, it stimulates insulin secretion in response to food intake. However, GIP also acts on adipocytes and muscle tissue in ways that GLP-1 does not — it promotes lipid uptake in fat cells under normal conditions and may improve insulin sensitivity in muscle. In individuals with obesity and type 2 diabetes, GIP receptor activity is often blunted, which initially made researchers skeptical of its therapeutic value. Tirzepatide demonstrated that stimulating the GIP receptor simultaneously with GLP-1 — rather than alone — restores and amplifies the metabolic response.

The Co-Agonist Mechanism

Tirzepatide is a single 39-amino acid peptide engineered to bind both GIP-R and GLP-1-R with high affinity. Its backbone is based on the native GIP sequence with modifications to enable GLP-1 receptor binding and albumin attachment. The co-agonism is not simply additive — the simultaneous activation of both receptors appears to produce synergistic effects in metabolic tissues, particularly in reducing hepatic fat accumulation and improving insulin sensitivity beyond what either agonist achieves alone.

SURMOUNT Trial Data

The SURMOUNT-1 Phase 3 trial demonstrated mean body weight loss of 20.9% at the highest dose (15mg/week) after 72 weeks — meaningfully exceeding the STEP trial results for semaglutide. Importantly, approximately 57% of participants on 15mg achieved ≥20% body weight loss, a threshold previously associated only with bariatric surgery outcomes.

Mass Spec Verification Is Non-Negotiable

Tirzepatide's molecular weight is ~4,813 Da. Because it is a modified peptide with a C18 fatty diacid chain (similar to semaglutide), HPLC alone cannot confirm identity — it can only confirm that a major peak exists at a certain retention time. Mass spectrometry must confirm the correct molecular ion. Researchers sourcing tirzepatide should insist on LC-MS/MS data, not just HPLC chromatograms, as the structural modification is what defines the compound.